Gamma-secretase inhibitor DAPT suppresses glioblastoma growth via uncoupling of tumor vessel density from vessel function

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

(2011) M. K. Gule et al.   CLINICAL CANCER RESEARCH

PPARδ agonists suppress angiogenesis in a VEGFR2-dependent manner

(2010) Markus Meissner et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells

(2010) Clare Ulyatt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

(2010) Lars Jakobsson et al.   NATURE CELL BIOLOGY

Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model

(2009) Shigeo Masuda et al.   CANCER SCIENCE

VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2

(2009) Z Zhang et al.   CELL DEATH AND DIFFERENTIATION

Notch signal is sufficient to direct an endothelial conversion from non-endothelial somitic cells conveyed to the aortic region by CXCR4

(2009) Emi Ohata et al.   DEVELOPMENTAL BIOLOGY

Angiogenesis: A Team Effort Coordinated by Notch

(2009) L.-K. Phng et al.   DEVELOPMENTAL CELL

GalNAcα1-3Gal, a new prognostic marker for cervical cancer

(2009) Qian Li et al.   INTERNATIONAL JOURNAL OF CANCER

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells

(2007) Laura S. Harrington et al.   MICROVASCULAR RESEARCH